Pharmaceuticals, Biotechnology and Life Sciences
Proceeds will enable advancement and acceleration of the Company’s transformative drug discovery programs derived from digital search of the fungal…
— First and only prescription therapy approved specifically for short-term treatment of the signs and symptoms of dry eye disease…
WALTHAM, Mass.–(BUSINESS WIRE)–TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR)-engineered T cell therapies in oncology,…
— First and only prescription therapy approved specifically for short-term treatment of the signs and symptoms of dry eye disease…
— First and only prescription therapy approved specifically for short-term treatment of the signs and symptoms of dry eye disease…
NEW YORK & TORONTO–(BUSINESS WIRE)–Cyclica announced the election of Sastry Chilukuri to its Board of Directors effective immediately. Chilukuri was…
Financing round led by Mass General Brigham Ventures and Sanofi Ventures Proceeds to support advancement of the lead autoimmune program…
NEW YORK & TORONTO–(BUSINESS WIRE)–Cyclica announced the election of Sastry Chilukuri to its Board of Directors effective immediately. Chilukuri was…
NEW YORK & TORONTO–(BUSINESS WIRE)–Cyclica announced the election of Sastry Chilukuri to its Board of Directors effective immediately. Chilukuri was…
NEW YORK & TORONTO–(BUSINESS WIRE)–Cyclica announced the election of Sastry Chilukuri to its Board of Directors effective immediately. Chilukuri was…